Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Pinter-Brown

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|January 26, 2010
Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussionJonathan Said, Lauren Pinter-Brown
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCLDanielle Brazel, Lauren Pinter-Brown
Drug Design, Development and Therapy|September 28, 2020
Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient SelectionAmanda L Blackmon, Lauren Pinter-Brown
Dermatology Online Journal|August 3, 2010
Severe cutaneous interface drug eruption associated with bendamustineHabibollah S Alamdari, Lauren Pinter-Brown, David S Cassarino, et al.
Cutis|September 5, 2003
Regression of cutaneous intravascular lymphoma with rituximabKaren Han, Jennifer C Haley, Keith Carlson, et al.
Frontiers in Immunology|May 15, 2024
Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysisDanielle Brazel, Christopher Grant, Angelo Cabal, et al.
Clinical Lymphoma|July 13, 2004
Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphomaChristos Emmanouilides, Christos Colovos, Lauren Pinter-Brown, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Leukemia & Lymphoma|August 21, 2025
Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphomaPiyatida Chumnumsiriwath, Pongthep Vittayawacharin, Lauren Pinter-Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2003
Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylationAlice A Roberts, Maho Amano, Christopher Felten, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|January 26, 2010
Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussionJonathan Said, Lauren Pinter-Brown
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCLDanielle Brazel, Lauren Pinter-Brown
Drug Design, Development and Therapy|September 28, 2020
Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient SelectionAmanda L Blackmon, Lauren Pinter-Brown
Dermatology Online Journal|August 3, 2010
Severe cutaneous interface drug eruption associated with bendamustineHabibollah S Alamdari, Lauren Pinter-Brown, David S Cassarino, et al.
Cutis|September 5, 2003
Regression of cutaneous intravascular lymphoma with rituximabKaren Han, Jennifer C Haley, Keith Carlson, et al.
Frontiers in Immunology|May 15, 2024
Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysisDanielle Brazel, Christopher Grant, Angelo Cabal, et al.
Clinical Lymphoma|July 13, 2004
Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphomaChristos Emmanouilides, Christos Colovos, Lauren Pinter-Brown, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Leukemia & Lymphoma|August 21, 2025
Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphomaPiyatida Chumnumsiriwath, Pongthep Vittayawacharin, Lauren Pinter-Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2003
Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylationAlice A Roberts, Maho Amano, Christopher Felten, et al.
Pageof 4